Driehaus Capital Management LLC Sells 109,214 Shares of LeMaitre Vascular, Inc. $LMAT

Key Points

• Driehaus Capital Management has decreased its stake in LeMaitre Vascular by 41.5%, selling 109,214 shares, and now holds approximately 0.68% of the company valued at $12.9 million.
• CEO George W. Lemaitre sold 100,000 shares for over $9.35 million, reducing his ownership by 5.47% to 1.73 million shares, valued at approximately $161.5 million.
• The company reported a 15% increase in revenue year-over-year with earnings per share of $0.60, surpassing analyst expectations of $0.57 per share.

Driehaus Capital Management LLC trimmed its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 41.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 154,006 shares of the medical instruments supplier's stock after selling 109,214 shares during the quarter. Driehaus Capital Management LLC owned 0.68% of LeMaitre Vascular worth $12,921,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Opal Wealth Advisors LLC purchased a new position in shares of LeMaitre Vascular in the first quarter valued at about $26,000. NBC Securities Inc. purchased a new stake in LeMaitre Vascular in the 1st quarter worth approximately $36,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of LeMaitre Vascular in the 1st quarter worth approximately $50,000. US Bancorp DE raised its holdings in shares of LeMaitre Vascular by 36.0% during the first quarter. US Bancorp DE now owns 1,390 shares of the medical instruments supplier's stock valued at $117,000 after acquiring an additional 368 shares in the last quarter. Finally, Cetera Investment Advisers boosted its holdings in LeMaitre Vascular by 11.5% in the fourth quarter. Cetera Investment Advisers now owns 2,753 shares of the medical instruments supplier's stock valued at $254,000 after acquiring an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company's stock.

Insider Buying and Selling

In related news, CEO George W. Lemaitre sold 100,000 shares of the firm's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $93.51, for a total transaction of $9,351,000.00. Following the sale, the chief executive officer directly owned 1,727,003 shares in the company, valued at approximately $161,492,050.53. This trade represents a 5.47% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Bridget A. Ross sold 2,500 shares of LeMaitre Vascular stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $94.00, for a total transaction of $235,000.00. Following the completion of the transaction, the director directly owned 2,916 shares of the company's stock, valued at $274,104. This trade represents a 46.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 120,815 shares of company stock worth $11,280,206. Insiders own 9.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Barrington Research upgraded shares of LeMaitre Vascular from a "market perform" rating to an "outperform" rating and set a $95.00 price target on the stock in a research report on Wednesday, August 6th. Cantor Fitzgerald boosted their price objective on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the company a "neutral" rating in a report on Wednesday, August 6th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, LeMaitre Vascular currently has a consensus rating of "Hold" and a consensus target price of $97.60.

LeMaitre Vascular Stock Up 2.7%

LMAT stock traded up $2.60 during trading on Thursday, hitting $97.16. 81,551 shares of the company's stock traded hands, compared to its average volume of 189,709. The company has a quick ratio of 11.74, a current ratio of 13.96 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $2.20 billion, a P/E ratio of 47.27, a PEG ratio of 2.45 and a beta of 0.79. LeMaitre Vascular, Inc. has a 1 year low of $71.42 and a 1 year high of $109.58. The business has a fifty day simple moving average of $88.05 and a two-hundred day simple moving average of $86.35.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.57 by $0.03. The company had revenue of $63.15 million during the quarter, compared to the consensus estimate of $62.48 million. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. The firm's quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.52 earnings per share. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Sell-side analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 4th. Stockholders of record on Thursday, August 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Thursday, August 21st. LeMaitre Vascular's payout ratio is presently 38.83%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.